APROGEN BIOLOGICS

The current price of 003060 is 1603 KRW — it has decreased by 3.43% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange APROGEN BIOLOGICS stocks are traded under the ticker 003060.

003060 stock is 6.41% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is APROGEN BIOLOGICS there?

Yes, you can track APROGEN BIOLOGICS financials in yearly and quarterly reports right on TradingView.

003060 stock has fallen by 6.75% compared to the previous week, the month change is a 21.03% fall, over the last year APROGEN BIOLOGICS has showed a 56.08% decrease.

003060 net income for the last quarter is ‪−96.80 B‬ KRW, while the quarter before that showed ‪−4.86 B‬ KRW of net income which accounts for ‪−1.89 K‬% change. Track more APROGEN BIOLOGICS financial stats to get the full picture.

No, 003060 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 003060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APROGEN BIOLOGICS stock right from TradingView charts — choose your broker and connect to your account.

003060 reached its all-time high on Jul 13, 2004 with the price of 886220 KRW, and its all-time low was 1467 KRW and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 425.00 employees. See our rating of the largest employees — is APROGEN BIOLOGICS on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APROGEN BIOLOGICS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APROGEN BIOLOGICS stock shows the sell signal. See more of APROGEN BIOLOGICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APROGEN BIOLOGICS EBITDA is ‪−49.29 B‬ KRW, and current EBITDA margin is −56.42%. See more stats in APROGEN BIOLOGICS financial statements.